Preliminary study on chronic granulomatous disease in Sri Lanka
Autor: | W. M. D. K. Dasanayake, Aruna D. De Silva, Noorul Mifra Faiz, Shalinda Jude Arjuna Fernando, Rathnayake Mudiyanselage Chandima Hasanthi Karunatilake, Geethani Devika Wickramasinghe, Nilhan Rajiva de Silva, Shiroma Mangaika Handunnetti |
---|---|
Rok vydání: | 2018 |
Předmět: |
lcsh:Immunologic diseases. Allergy
Tuberculosis Disease CYBB 03 medical and health sciences 0302 clinical medicine Chronic granulomatous disease Germline mutation medicine NCF1 X-linked Splice site mutation NADPH oxidase business.industry Mortality rate General Medicine medicine.disease 030220 oncology & carcinogenesis Mycobacterial infections Immunology Primary immunodeficiency lcsh:RC581-607 business 030215 immunology |
Zdroj: | Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-11 (2018) |
ISSN: | 1710-1492 |
DOI: | 10.1186/s13223-018-0264-7 |
Popis: | Background Chronic granulomatous disease (CGD) is a rare primary immunodeficiency of the phagocytic cells, which results in absent or diminished levels of microbicidal reactive oxygen species. The disease occurs due to germline mutations in the genes encoding the five subunits of NADPH oxidase complex. The present study is a pilot study to understand the clinical and genetic aspects of CGD in Sri Lanka. Methods Clinical records of thirteen CGD patients were analysed and compared with similar studies performed in different countries and regions to identify patterns in demographics, clinical manifestations and infectious agents. Genomic DNA and cDNA were analysed in eight patients to identify mutations in CYBB and NCF1 genes, thereby to ascertain the potential X-linked and autosomal recessive (AR) CGD patients. Results The onset of symptoms in the patient cohort was very early (mean 4.6 months) compared to 20 months in India and 23.9 months in Latin America. Similarly, the age at diagnosis was lower (mean 1.6 years after birth) compared to other studies; 4.5 years in India and 6.1 years in Europe. Pulmonary manifestations were the most common (85%), followed by skin/subcutaneous infections (77%) and lymphadenopathy (62%). The death rate of local patients (38%) was higher than other countries (India 35%, Europe 20%). Majority (77%) were treated for tuberculosis at some point in life. Genetic analysis confirmed six out of eight patients as X-linked CGD cases with mutations in CYBB gene. A novel splice site mutation was identified in P-07 at position c.141+6 which resulted in the deletion of entire exon 2. Two siblings (P-05 and P-06) from consanguineous parents, were identified with AR-CGD based on the homozygous GT deletion mutation in NCF1 gene. Conclusions The clinical presentation, manifestations and genetic subtypes in the local cohort, appear to be comparable with global trends. Mycobacterial infections should be investigated and treated with more prominence. Effective treatment options are required to control the high mortality rate. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |